The intradermal injections market in Asia Pacific is expected to grow from US$ 774.05 million in 2021 to US$ 1,698.43 million by 2028. It is estimated to grow at a CAGR of 11.9% from 2021 to 2028.

Developed and Developing Countries Provide Significant Growth Opportunities to Market

Health systems in developing economies focus on introducing various advanced therapeutic, diagnostic, and aesthetic technologies into their service portfolios to be able to provide healthcare facilities with high efficiency. In developed countries, intradermal devices have received significant acceptance in vaccination and cosmetic procedures. In developing countries, although these devices are mainly used in vaccination, tuberculosis diagnosis, and aesthetic procedures, the market is currently in a nascent stage of development. Many developing countries are attractive destinations for medical tourism, especially for aesthetic procedures due to the lower costs of these procedures than developed countries. Health facilities, medical spas, and wellness centers in developing countries are increasingly offering a comprehensive range of inexpensive but high-quality medical-aesthetic procedures, which, eventually, triggers the demand for intradermal injections. The leading manufacturers of intradermal injections are developing ideal devices and collaborating with other players to improve the therapeutic efficacy of existing and new drugs. Asia Pacific is expected to be the fastest-growing market for intradermal injections among all major regions, with countries such as China, Japan, India, and South Korea being prime contributors to the market growth, during the forecast period. The rapid pace of urbanization, surging investments by healthcare providers in improving infrastructure, growing awareness among the population, and increasing availability of a range of advanced products and technologies are all contributing to the growth of this market.

Market Overview
The Asia Pacific intradermal injections market is segmented into Australia, China, India, Japan, South Korea, and Rest of APAC. The market growth in the region is ascribed to the growing investments from international players in China and India with greater government support, expanding base of CRO service providers, and advancements in healthcare infrastructure. The medical device industry in China has grown at a faster pace in the past several years. This growth can be attributed to China’s 13th Five-Year Plan that prioritizes health and innovation, increased demand for technologically advanced medical devices, significantly rising geriatric population, and growing chronic health conditions among people. In addition, the availability of low-cost and skilled laborers and massive space for production facilities have encouraged various market leaders to have their production plants in China. The Population Reference Bureau has projected that 366 million people in China will be aged 65 or more by 2050. Per the WHO’s Ageing and Health in China, in 2019, ~75% of people with age 60 and above suffered from noncommunicable diseases, such as cardiovascular disease, diabetes, and hypertension. The R&D sector of China is focused on develop devices for painless delivery of drugs via intradermal route, which can specifically of help during the procedures involving elderly populations.

Asia Pacific Intradermal Injections Market Revenue and Forecast to 2028 (US$ Million)

Asia Pacific Intradermal Injections Market Segmentation

The Asia Pacific intradermal injections market is segmented on the basis of method, application, end user, and country. Based on method, the market is segmented into normal sized needle, short needle, and without needle. The normal sized needles segment registered the largest market share in 2021. The normal sized needles segment is further subsegmented into intradermal microinjections, microneedle arrays, and tattoo devices. The short needle segment is bifurcated into intradermal liquid jet injectors and ballistic intradermal injectors. In terms of application, the Asia Pacific intradermal injections market is segmented into tuberculin skin test, allergy test, local aesthetics, and others. The tuberculin skin test segment held the largest market share in 2021. The Asia Pacific intradermal injections market, by end user, is segmented into hospitals, diagnostic laboratories, academics and research institutes, and others. The hospitals segment held the largest market share in 2021. Based on country, the market is segmented into Australia, China, India, Japan, South Korea, and rest of Asia Pacific. China dominated the market share in 2021.

BD; West Pharmaceutical Services, Inc; Terumo Corporation; Nanopass; PharmaJet; Idevax; Eunsung Global; Crossject; Cardinal Health Inc; and Hindustan Syringes and Medical Devices Ltd are the leading companies operating in intradermal injections market in the Asia Pacific region.

TABLE OF CONTENTS

1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 APAC Intradermal Injections Market – By Method
1.3.2 APAC Intradermal Injections Market – By Application
1.3.3 APAC Intradermal Injections Market – By End User
1.3.4 APAC Intradermal Injections Market – By Country
2. Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. APAC Intradermal Injections Market Landscape
4.1 Overview
4.2 APAC PEST ANALYSIS
4.3 EXPERT OPINIONS
5. APAC Intradermal Injections Market – Key Market Dynamics
5.1 Key Market Drivers
5.1.1 Increasing Intradermal Vaccination
5.1.2 Increasing Incidences of diseases
5.1.3 Rising Acceptance of Aesthetic Procedures
5.2 Key Market Restraints
5.2.1 Risks, Complications, and Dosing Limitations Associated with Intradermal Injections
5.3 Key Market Opportunities
5.3.1 Significant Growth Opportunities in Developed as Well As Developing Countries
5.4 Future Trends
5.4.1 Strategic Developments by Manufacturers
5.5 Impact Analysis of Drivers and Restraints
6. Intradermal Injections Market– APAC Analysis
6.1 APAC Intradermal Injections Market, By Country – Forecast and Analysis
7. APAC Intradermal Injections Market Revenue And Forecasts To 2028– By Method
7.1 Overview
7.2 APAC Intradermal Injections Market, By Method, 2021 & 2028 (%)
7.3 Normal-Sized Needles (MANTOUX)
7.3.1 Overview
7.3.2 Normal-Sized Needles (Mantoux): Intradermal Injection Market Revenue and Forecasts To 2028 (US$ MN)
7.4 Short Needles
7.4.1 Overview
7.4.2 Short Needles: Intradermal Injection Market Revenue and Forecast to 2028 (US$ Million)
7.4.3 Intradermal Microinjection
7.4.3.1 Overview
7.4.3.2 Intradermal Microinjection: Intradermal Injection Market Revenue and Forecast to 2028 (US$ Million)
7.4.4 Microneedle Arrays
7.4.4.1 Overview
7.4.4.2 Microneedle Arrays: Intradermal Injection Market Revenue and Forecast to 2028 (US$ Million)
7.4.5 Tattoo Devices
7.4.5.1 Overview
7.4.5.2 Tattoo Devices: Intradermal Injection Market Revenue and Forecast to 2028 (US$ Million)
7.5 Without Needles
7.5.1 Overview
7.5.2 Without Needles: Intradermal Injection Market Revenue and Forecast to 2028 (US$ Million)
7.5.3 Intradermal Liquid Jet Injectors
7.5.3.1 Overview
7.5.3.2 Intradermal Liquid Jet Injectors: Intradermal Injection Market Revenue and Forecast to 2028 (US$ Million)
7.5.4 Ballistic Intradermal Injectors
7.5.4.1 Overview
7.5.4.2 Ballistic Intradermal Injectors: Intradermal Injection Market Revenue and Forecast to 2028 (US$ Million)
8. APAC Intradermal Injections Market Revenue and Forecasts To 2028 – Application
8.1 Overview
8.2 APAC Intradermal Injections Market Share by Application – 2021 & 2028 (%)
8.3 Tuberculin Skin Testing
8.3.1 Overview
8.3.2 Tuberculin Skin Testing Market Revenue and Forecast to 2028 (US$ Million)
8.4 Allergy Testing
8.4.1 Overview
8.4.2 Allergy Testing Market Revenue and Forecast to 2028 (US$ Million)
8.5 Local Aesthetics
8.5.1 Overview
8.5.2 Local Aesthetics Market Revenue and Forecast to 2028 (US$ Million)
8.6 OTHERS
8.6.1 Overview
8.6.2 Others Market Forecast and Analysis
9. APAC Intradermal Injections Market Analysis – End User
9.1 Overview
9.2 APAC Intradermal Injections Market, By End User, 2021 & 2028 (%)
9.3 Hospitals
9.3.1 Overview
9.3.2 Hospitals: Intradermal Injections Market Revenue and Forecast to 2028 (US$ Million)
9.4 Diagnostic Laboratories
9.4.1 Overview
9.4.2 Diagnostic Laboratories: Intradermal Injections Market Revenue and Forecast to 2028 (US$ Million)
9.5 Academic and Research Institutes
9.5.1 Overview
9.5.2 Academic and Research Institutes: Intradermal Injections Market Revenue and Forecast to 2028 (US$ Million)
9.6 OTHERS
9.6.1 Overview
9.6.2 Others: Intradermal Injections Market Revenue and Forecast to 2028 (US$ Million)
10. APAC Intradermal Injections Market Revenue and Forecasts To 2028 – Country Analysis
10.1 Asia Pacific Intradermal Injections Market Revenue and Forecasts To 2028
10.1.1 Overview
10.1.2 Asia Pacific: Intradermal Injections Market Revenue and Forecasts to 2028, By Country (%)
10.1.2.1 Japan: Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)
10.1.2.1.1 Overview
10.1.2.1.2 Japan: Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)
10.1.2.1.3 Japan: Intradermal Injections Market Revenue and Forecasts to 2028, By Method (US$ Million)
10.1.2.1.3.1 Japan: Intradermal Injections Market, by Short Needles, 2019–2028 (US$ Million)
10.1.2.1.3.2 Japan: Intradermal Injections Market, by Without Needles, 2019–2028 (US$ Million)
10.1.2.1.4 Japan: Intradermal Injections Market Revenue and Forecasts to 2028, By Application (US$ Million)
10.1.2.1.5 Japan: Intradermal Injections Market, by End User – Revenue and Forecast to 2028 (US$ Million)
10.1.2.2 China: Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)
10.1.2.2.1 Overview
10.1.2.2.2 China: Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)
10.1.2.2.3 China: Intradermal Injections Market Revenue and Forecasts to 2028, By Method (US$ Million)
10.1.2.2.3.1 China: Intradermal Injections Market, by Short Needles, 2019–2028 (US$ Million)
10.1.2.2.3.2 China: Intradermal Injections Market, by Without Needles, 2019–2028 (US$ Million)
10.1.2.2.4 China: Intradermal Injections Market Revenue and Forecasts to 2028, By Application (US$ Million)
10.1.2.2.5 China: Intradermal Injections Market, by End User – Revenue and Forecast to 2028 (US$ Million)
10.1.2.3 India Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)
10.1.2.3.1 Overview
10.1.2.3.2 India: Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)
10.1.2.3.3 India: Intradermal Injections Market Revenue and Forecasts to 2028, By Method (US$ Million)
10.1.2.3.3.1 India: Intradermal Injections Market, by Short Needles, 2019–2028 (US$ Million)
10.1.2.3.3.2 India: Intradermal Injections Market, by Without Needles, 2019–2028 (US$ Million)
10.1.2.3.4 India: Intradermal Injections Market Revenue and Forecasts to 2028, By Application (US$ Million)
10.1.2.3.5 India: Intradermal Injections Market, by End User – Revenue and Forecast to 2028 (US$ Million)
10.1.2.4 South Korea: Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)
10.1.2.4.1 Overview
10.1.2.4.2 South Korea: Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)
10.1.2.4.3 South Korea: Intradermal Injections Market Revenue and Forecasts to 2028, By Method (US$ Million)
10.1.2.4.3.1 South Korea: Intradermal Injections Market, by Short Needles, 2019–2028 (US$ Million)
10.1.2.4.3.2 South Korea: Intradermal Injections Market, by Without Needles, 2019–2028 (US$ Million)
10.1.2.4.4 South Korea: Intradermal Injections Market Revenue and Forecasts to 2028, By Application (US$ Million)
10.1.2.4.5 South Korea: Intradermal Injections Market, by End User – Revenue and Forecast to 2028 (US$ Million)
10.1.2.5 Australia: Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)
10.1.2.5.1 Overview
10.1.2.5.2 Australia: Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)
10.1.2.5.3 Australia: Intradermal Injections Market Revenue and Forecasts to 2028, By Method (US$ Million)
10.1.2.5.3.1 Australia: Intradermal Injections Market, by Short Needles, 2019–2028 (US$ Million)
10.1.2.5.3.2 Australia: Intradermal Injections Market, by Without Needles, 2019–2028 (US$ Million)
10.1.2.5.4 Australia: Intradermal Injections Market Revenue and Forecasts to 2028, By Application (US$ Million)
10.1.2.5.5 Australia: Intradermal Injections Market, by End User – Revenue and Forecast to 2028 (US$ Million)
10.1.2.6 Rest of Asia Pacific: Intradermal Injections Market – Revenue and Forecast to 2028 (US$ Million)
10.1.2.6.1 Overview
10.1.2.6.2 Rest of Asia Pacific: Intradermal Injections Market – Revenue and Forecast to 2028 (US$ Million)
10.1.2.6.3 Rest of Asia Pacific: Intradermal Injections Market Revenue and Forecasts to 2028, By Method (US$ Million)
10.1.2.6.3.1 Rest of Asia Pacific: Intradermal Injections Market, by Short Needles, 2019–2028 (US$ Million)
10.1.2.6.3.2 Rest of Asia Pacific: Intradermal Injections Market, by Without Needles, 2019–2028 (US$ Million)
10.1.2.6.4 Rest of Asia Pacific: Intradermal Injections Market Revenue and Forecasts to 2028, By Application (US$ Million)
10.1.2.6.5 Rest of Asia Pacific: Intradermal Injections Market, by End User – Revenue and Forecast to 2028 (US$ Million)
11. Industry Landscape
11.1 Overview
11.2 Developments
11.2.1 Overview
12. Company Profiles
12.1 BD
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 West Pharmaceutical Services, Inc.
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Terumo Corporation
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 NanoPass
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Pharmajet
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Idevax
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 EUNSUNG GLOBAL
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Crossject
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Cardinal Health Inc.
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 Hindustan Syringes and Medical Devices Ltd
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Glossary of Terms

LIST OF TABLES

Table 1. Japan: Intradermal Injections Market Revenue and Forecasts to 2028, By Method (US$ Million)
Table 2. Japan: Intradermal Injections Market, by Short Needles – Revenue and Forecast to 2028 (US$ Million)
Table 3. Japan: Intradermal Injections Market, by Without Needles – Revenue and Forecast to 2028 (US$ Million)
Table 4. Japan: Intradermal Injections Market Revenue and Forecasts to 2028, By Application (US$ Million)
Table 5. Japan: Intradermal Injections Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 6. China: Intradermal Injections Market Revenue and Forecasts to 2028, By Method (US$ Million)
Table 7. China: Intradermal Injections Market, by Short Needles – Revenue and Forecast to 2028 (US$ Million)
Table 8. China: Intradermal Injections Market, by Without Needles – Revenue and Forecast to 2028 (US$ Million)
Table 9. China: Intradermal Injections Market Revenue and Forecasts to 2028, By Application (US$ Million)
Table 10. China: Intradermal Injections Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 11. India: Intradermal Injections Market Revenue and Forecasts to 2028, By Method (US$ Million)
Table 12. India: Intradermal Injections Market, by Short Needles – Revenue and Forecast to 2028 (US$ Million)
Table 13. India: Intradermal Injections Market, by Without Needles – Revenue and Forecast to 2028 (US$ Million)
Table 14. India: Intradermal Injections Market Revenue and Forecasts to 2028, By Application (US$ Million)
Table 15. India: Intradermal Injections Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 16. South Korea: Intradermal Injections Market Revenue and Forecasts to 2028, By Method (US$ Million)
Table 17. South Korea: Intradermal Injections Market, by Short Needles – Revenue and Forecast to 2028 (US$ Million)
Table 18. South Korea: Intradermal Injections Market, by Without Needles – Revenue and Forecast to 2028 (US$ Million)
Table 19. South Korea: Intradermal Injections Market Revenue and Forecasts to 2028, By Application (US$ Million)
Table 20. South Korea: Intradermal Injections Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 21. Australia: Intradermal Injections Market Revenue and Forecasts to 2028, By Method (US$ Million)
Table 22. Australia: Intradermal Injections Market, by Short Needles – Revenue and Forecast to 2028 (US$ Million)
Table 23. Australia: Intradermal Injections Market, by Without Needles – Revenue and Forecast to 2028 (US$ Million)
Table 24. Australia: Intradermal Injections Market Revenue and Forecasts to 2028, By Application (US$ Million)
Table 25. Australia: Intradermal Injections Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 26. Rest of Asia Pacific: Intradermal Injections Market Revenue and Forecasts to 2028, By Method (US$ Million)
Table 27. Rest of Asia Pacific: Intradermal Injections Market, by Short Needles – Revenue and Forecast to 2028 (US$ Million)
Table 28. Rest of Asia Pacific: Intradermal Injections Market, by Without Needles – Revenue and Forecast to 2028 (US$ Million)
Table 29. Rest of Asia Pacific: Intradermal Injections Market Revenue and Forecasts to 2028, By Application (US$ Million)
Table 30. Rest of Asia Pacific: Intradermal Injections Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 31. Developments Done by Companies
Table 32. Glossary of Terms

LIST OF FIGURES

Figure 1. APAC Intradermal Injections Market Segmentation
Figure 2. APAC Intradermal Injections Market, By Country
Figure 3. APAC Intradermal Injections Market Overview
Figure 4. APAC Intradermal Injection Market, By Method
Figure 5. APAC Intradermal Injection Market, By Country
Figure 6. Asia-Pacific PEST Analysis
Figure 7. EXPERT OPINIONS
Figure 8. APAC Intradermal Injection Market Impact Analysis of Drivers and Restraints
Figure 9. APAC Intradermal Injections Market – Revenue Forecast and Analysis – 2019- 2028
Figure 10. APAC Intradermal Injections Market, by Method, 2021 & 2028 (%)
Figure 11. APAC Normal-Sized Needles (Mantoux): Intradermal Injection Market Revenue and Forecasts to 2028 (US$ Million)
Figure 12. APAC Short Needles: Intradermal Injection Market Revenue and Forecasts to 2028 (US$ Million)
Figure 13. APAC Intradermal Microinjection: Intradermal Injection Market Revenue and Forecasts to 2028 (US$ Million)
Figure 14. APAC Microneedle Arrays: Intradermal Injection Market Revenue and Forecasts to 2028 (US$ Million)
Figure 15. APAC Tattoo Devices: Intradermal Injection Market Revenue and Forecasts to 2028 (US$ Million)
Figure 16. APAC Without Needle: Intradermal Injection Market Revenue and Forecasts to 2028 (US$ Million)
Figure 17. APAC Intradermal Liquid Jet Injectors: Intradermal Injection Market Revenue and Forecasts to 2028 (US$ Million)
Figure 18. APAC Ballistic Intradermal Injectors: Intradermal Injection Market Revenue and Forecasts to 2028 (US$ Million)
Figure 19. APAC Intradermal Injections Market Share by Application – 2021 & 2028 (%)
Figure 20. APAC Tuberculin Skin Test Market Revenue and Forecasts to 2028 (US$ Million)
Figure 21. APAC Allergy Testing Market Revenue and Forecasts to 2028 (US$ Million)
Figure 22. APAC Local Aesthetic Market Revenue and Forecasts to 2028 (US$ Million)
Figure 23. APAC Others Intradermal Market Revenue and Forecasts to 2028 (US$ Million)
Figure 24. APAC Intradermal Injections Market, by End User, 2021 & 2028 (%)
Figure 25. APAC Hospital: Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)
Figure 26. APAC Diagnostic Laboratories: Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)
Figure 27. APAC Academic & Research Institutes: Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)
Figure 28. APAC Others: Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)
Figure 29. Asia Pacific Intradermal Injections Market Overview, by Country- Revenue (2021) (US$ Million)
Figure 30. Asia Pacific: Intradermal Injections Market Revenue and Forecasts to 2028, By Country (%)
Figure 31. Japan: Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)
Figure 32. China: Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)
Figure 33. India: Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)
Figure 34. South Korea: Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)
Figure 35. Australia: Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)
Figure 36. Rest of Asia Pacific: Intradermal Injections Market – Revenue and Forecast to 2028 (US$ Million)

● Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Asia Pacific intradermal injections market.
● Highlights key business priorities in order to assist companies to realign their business strategies
● The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific intradermal injections market, thereby allowing players across the value chain to develop effective long-term strategies
● Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
● Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the intradermal injections market, as well as those hindering it
● Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

The List of Companies – Asia Pacific Intradermal Injections Market

● BD.
● West Pharmaceutical Services, Inc.
● Terumo Corporation.
● Nanopass.
● PharmaJet.
● Idevax.
● Eunsung Global.
● Crossject.
● Cardinal Health Inc.
● Hindustan Syringes and Medical Devices Ltd.

At 11.9% CAGR, the Asia Pacific Intradermal Injection Market is speculated to be worth US$ 1,698.43 million by 2028, says The Insight Partners

According to the Insight Partners’ research, the Asia Pacific intradermal injection market was valued at US$ 774.05 million in 2021 and is expected to reach US$ 1,698.43 million by 2028, registering an annual growth rate of 11.9% from 2021 to 2028.Significant growth opportunities in developed as well as developing countries and strategic developments by manufacturers are the critical factors attributed to the market expansion.

Manufacturers in the Asia Pacific Intradermal Injection market are adopting developmental strategies such as partnerships, collaborations, product launches, approvals, and mergers and acquisitions to sustain the competitive environment in the market. The companies are also undertaking the partnerships activities to strengthen their presence in the market and to boost the clinical research work for speeding up the development of various new candidates. The medical equipment manufacturers across the world are scaling up the production of their devices. Their involvement in various business developments and product innovations helps ensure the easy availability of the products in the regional markets. Moreover, the regulatory agencies are providing the required support through timely product approvals and permissions. Such strategic activities by manufacturers are expected to propel the growth of the ASIA PACIFIC intradermal injection market in coming years.

On the contrary, risks, complications, and dosing limitations associated with intradermal injections hurdles the growth of Asia Pacific intradermal injection market.

Based on method, the Asia Pacific intradermal injection market is segmented into normal sized needles, short needle, and without needle. The normal sized needles segment held 41.7% market share in 2021, amassing US$ 322.77 million. It is projected to garner US$ 683.12 million by 2028 to expand at 11.3% CAGR during 2021–2028. The normal sized needles segment is further subsegmented into intradermal microinjection, microneedle arrays, and tattoo devices. The short needle segment is further subsegmented intradermal liquid jet injectors and ballistic intradermal injectors. Based on application, the Asia Pacific intradermal injection market is segmented into tuberculin skin test, allergy test, local aesthetics, and others. The tuberculin skin test segment held 30.2% market share in 2021, amassing US$ 234.03 million. It is projected to garner US$ 505.49 million by 2028 to expand at 11.6% CAGR during 2021–2028. Based on end user, the Asia Pacific intradermal injection market is segmented into hospitals, diagnostic laboratories, academics and research institutes, and others. The hospitals segment held 39.7% market share in 2021, amassing US$ 306.99 million. It is projected to garner US$ 679.74 million by 2028 to expand at 12.0% CAGR during 2021–2028. Based on country, the Asia Pacific intradermal injection market has been categorized into Australia, China, India, Japan, South Korea, and rest of APAC. Our regional analysis states that China captured 39.4% market share in 2021. It was assessed at US$ 304.65 million in 2021 and is likely to hit US$ 676.73 million by 2028, exhibiting a CAGR of 12.1% during the forecast period. Key players profiles in the Asia Pacific intradermal injection market report are BD; West Pharmaceutical Services, Inc; Terumo Corporation; Nanopass; PharmaJet; Idevax; Eunsung Global; Crossject; Cardinal Health Inc; and Hindustan Syringes and Medical Devices Ltd among others.